Characteristic | Number of patients [cases (%)] |
---|---|
Gleason score | |
 ≤ 6 | 274 (46.0) |
 7 | 240 (40.3) |
 ≥ 8 | 82 (13.8) |
T stage | |
 T1–T2b | 577 (96.8) |
 T2c | 5 (0.8) |
 ≥ T3 | 14 (2.3) |
Pretreatment PSA level (mg/dL) | |
 ≤ 10 | 467 (78.4) |
 > 10 and ≤ 20 | 98 (16.4) |
 > 20 | 31 (5.2) |
D’Amico category | |
 Low risk | 226 (37.9) |
 Intermediate risk | 264 (44.3) |
 High risk | 106 (17.8) |
ADT in risk groups | |
 Low-risk | 48 (21.2) |
 Intermediate-risk | 208 (78.8) |
 High-risk | 105 (99.1) |